Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance

L Thomas, WP Abhayaratna - JACC: Cardiovascular Imaging, 2017 - jacc.org
The left atrium is considered a biomarker for adverse cardiovascular outcomes, particularly
in patients with left ventricular diastolic dysfunction and atrial fibrillation in whom left atrial …

Left Atrial Reverse Remodeling

L Thomas, WP Abhayaratna - JACC: Cardiovascular Imaging, 2017 - infona.pl
The left atrium is considered a biomarker for adverse cardiovascular outcomes, particularly
in patients with left ventricular diastolic dysfunction and atrial fibrillation in whom left atrial …

[引用][C] Left Atrial Reverse Remodeling

L Thomas, WP Abhayaratna - JACC: Cardiovascular Imaging, 2017 - cir.nii.ac.jp

Left Atrial Reverse Remodeling: Mechanisms, Evaluation, and Clinical Significance

L Thomas, WP Abhayaratna - JACC: Cardiovascular Imaging, 2017 - research.monash.edu
The left atrium is considered a biomarker for adverse cardiovascular outcomes, particularly
in patients with left ventricular diastolic dysfunction and atrial fibrillation in whom left atrial …

Left Atrial Reverse Remodeling: Mechanisms, Evaluation, and Clinical Significance.

L Thomas, WP Abhayaratna - JACC. Cardiovascular Imaging, 2017 - europepmc.org
The left atrium is considered a biomarker for adverse cardiovascular outcomes, particularly
in patients with left ventricular diastolic dysfunction and atrial fibrillation in whom left atrial …

[HTML][HTML] Left Atrial Reverse Remodeling: Mechanisms, Evaluation, and Clinical Significance

L Thomas, WP Abhayaratna - JACC: Cardiovascular Imaging, 2017 - Elsevier
The left atrium is considered a biomarker for adverse cardiovascular outcomes, particularly
in patients with left ventricular diastolic dysfunction and atrial fibrillation in whom left atrial …

Left Atrial Reverse Remodeling: Mechanisms, Evaluation, and Clinical Significance

L Thomas, WP Abhayaratna - JACC. Cardiovascular …, 2017 - pubmed.ncbi.nlm.nih.gov
The left atrium is considered a biomarker for adverse cardiovascular outcomes, particularly
in patients with left ventricular diastolic dysfunction and atrial fibrillation in whom left atrial …